{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:46:05Z","timestamp":1782708365378,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To clarify the correlation between clinicopathological features and gene mutation status in bronchial biopsy tissues and matched bronchial brushing cytology specimens from patients with non-small cell lung cancer (NSCLC), with a focus on verifying the concordance of driver gene detection between the two types of specimens, so as to provide high-quality clinical evidence for specimen selection in gene testing for NSCLC targeted therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 160 bronchial biopsy tissue specimens from NSCLC patients pathologically diagnosed in our hospital from January 2023 to December 2025 were enrolled, among which 120 paired qualified bronchial brushing cytology specimens were included as the research objects. Amplification refractory mutation system polymerase chain reaction (ARMS-PCR) was performed to detect common driver genes of NSCLC in the two types of specimens. Clinicopathological data including gender, age, smoking history, lymph node metastasis status and pathological type were collected. SPSS 26.0 software was used for corresponding statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 160 bronchial biopsy tissue specimens, the percentage of gene mutations\/fusions was 63.75% (102\/160). Among the 120 biopsy tissue specimens with paired bronchial brushing cytology samples, the percentage was 68.33% (82\/120), while the percentage for the 120 paired bronchial brushing cytological specimens was 75.00% (90\/120); In the two types of paired specimens, the percentages of gene mutations\/fusions in female patients and lung adenocarcinoma patients were significantly higher than those in male patients and non-adenocarcinoma patients (P&amp;lt;0.05), whereas age, lymph node metastasis status, and smoking history showed no significant correlation with gene mutation status (P&amp;gt;0.05). The mutation profiles of both paired specimen types were predominantly epidermal growth factor receptor (EGFR) mutations, with EGFR mutation rates detected in 120 biopsy tissue samples at 43.33% and in cytological specimens at 50.83%.The overall concordance rate of genetic testing results between the two types of paired specimens reached 91.67%. The consistency test showed a Kappa value of 0.685 (P &amp;lt; 0.05), indicating a high degree of statistical consistency between the test results of the two specimen types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The gene mutation status of NSCLC patients is closely correlated with gender and pathological type.Paired bronchial brushing cytology specimens and bronchial biopsy tissue specimens collected synchronously exhibit high concordance in detecting NSCLC driver genes,and can be used as an effective supplementary specimen to bronchial biopsy tissues. It provides a new approach for gene detection in NSCLC patients who cannot tolerate invasive biopsy or have unqualified biopsy specimens, and facilitates the implementation of clinical precise targeted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1842742","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:26:56Z","timestamp":1782707216000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Concordance study of bronchial biopsy tissues and matched bronchial brushing cytology specimens in driver gene detection of non-small cell lung cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiongfeng","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijia","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahan","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fuwai Central China Cardiovascular Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241231260","article-title":"Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology","volume":"16","author":"Laguna","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2925","article-title":"Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR","volume":"6","author":"Ha","year":"2015","journal-title":"Oncotarget"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/annonc\/mdy554","article-title":"Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS","volume":"30","author":"Wu","year":"2019","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29070396","article-title":"Consensus recommendations to optimize testing for new targetable alterations in non-small cell lung cancer","volume":"29","author":"Ionescu","year":"2022","journal-title":"Curr Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2016.10.010","article-title":"Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers","volume":"102","author":"Chapman","year":"2016","journal-title":"Lung Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-2025-145","article-title":"Impact of smoking on the effectiveness of different non-small-cell lung cancer therapies","volume":"14","author":"Yang","year":"2025","journal-title":"Transl Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/his.15080","article-title":"Molecular pathology of non-small cell carcinoma","volume":"84","author":"Yatabe","year":"2024","journal-title":"Histopathology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241292782","article-title":"Targeting EGFR exon 20 insertion mutations in non-small-cell lung cancer: changes in treatment strategies are coming","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Control"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8074","article-title":"Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.08.004","article-title":"Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients","volume":"136","author":"Song","year":"2019","journal-title":"Lung Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-026-00829-6","article-title":"Interlesional heterogeneity of EGFR mutations: a systematic review and meta-analysis","volume":"30","author":"Rodr\u00edguez S\u00e1nchez","year":"2026","journal-title":"Mol Diagn Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.8.2501","article-title":"Lung cancer survival with current therapies and new targeted treatments: a comprehensive update from the Srinagarind Hospital-based Cancer Registry from (2013 to 2017)","volume":"22","author":"Musika","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000519380","article-title":"Concordance of cytological specimens with histological tissue for detection of epidermal growth factor receptor mutation in non-small cell lung cancer: a systematic review","volume":"66","author":"Chua","year":"2022","journal-title":"Acta Cytol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2022.10.17","article-title":"Biomarker testing of cytology specimens in personalized medicine for lung cancer patients","volume":"56","author":"Kim","year":"2022","journal-title":"J Pathol Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21774","article-title":"Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: a National Lung Cancer Roundtable best-practice guide","volume":"73","author":"Fox","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2021.100167","article-title":"Metastatic NSCLCs with limited tissues: how to effectively identify driver alterations to guide targeted therapy in Chinese patients","volume":"2","author":"Li","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050754","article-title":"Cytological samples: an asset for the diagnosis and therapeutic management of patients with lung cancer","volume":"12","author":"Frankel","year":"2023","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1186\/s12885-025-14770-0","article-title":"Prospective multicenter validation of a next-generation sequencing panel using cytology specimens for lung cancer: cPANEL","volume":"25","author":"Morikawa","year":"2025","journal-title":"BMC Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24404","article-title":"ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: the experience of Shanghai Pulmonary Hospital","volume":"48","author":"Cao","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.08.003","article-title":"Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: a UK expert consensus statement","volume":"172","author":"Navani","year":"2022","journal-title":"Lung Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1807-z","article-title":"ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens","volume":"141","author":"Liu","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6671","article-title":"Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.25259\/Cytojournal_73_2019","article-title":"Bronchial brushing cytology is comparable to bronchial biopsy for epidermal growth factor receptor mutation test in non-small cell lung cancer","volume":"17","author":"Koo","year":"2020","journal-title":"Cytojournal"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21322","article-title":"EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients","volume":"121","author":"Malapelle","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/PO-25-00299","article-title":"Enhanced detection of druggable mutations in non-small cell lung cancer using targeted collection of bronchial washing fluid compared with plasma and tumor tissue","volume":"9","author":"Kim","year":"2025","journal-title":"JCO Precis Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1842742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:26:57Z","timestamp":1782707217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1842742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":28,"alternative-id":["10.3389\/fonc.2026.1842742"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1842742","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1842742"}}